Boris Tolkachev
Analyst at Freedom Broker
Replay available
Intensity Therapeutics, Inc. (NASDAQ: INTS) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.

Analyst at Freedom Broker
President and Chief Executive Officer
Analyst at Alliance Global Partners
Chief Financial Officer
Analyst at Brookline Capital
Analyst at H.C. Wainwright
Watch the replay and follow the connected company analysis, news, and investor updates for Intensity Therapeutics, Inc..
WEBVTT 00:00:00.051 -- 00:00:05.294 Good morning and welcome to the Intensity Therapeutics second quarter 2026 financial 00:00:05.294 -- 00:00:07.575 results conference call. 00:00:07.575 -- 00:00:13.198 Joining the call today is Lewis H. Bender, Intensity's president and CEO, 00:00:13.198 -- 00:00:18.301 and Joseph Talamo, Intensity's chief financial officer. 00:00:18.301 -- 00:00:22.664 Shortly before this call, Intensity issued a press release announcing its second quarter 00:00:22.664 -- 00:00:27.781 2026 financial results. which is available under the news and events section 00:00:27.781 -- 00:00:30.103 of the company's website. 00:00:30.103 -- 00:00:35.508 Shortly after this webcast, a replay of this call will also be posted. 00:00:35.508 -- 00:00:40.212 Before we begin, the company reminds you that comments made by management during this 00:00:40.212 -- 00:00:45.216 conference call contain forward-looking statements that involve risks and uncertainties 00:00:45.216 -- 00:00:50.199 regarding the operations and future results of Intensity Therapeutics. 00:00:50.341 -- 00:00:55.200 These statements include but are not limited to Statements relating to the company's 00:00:55.200 -- 00:01:01.346 expected future plans, cash runway, development activities, projected milestones, 00:01:01.346 -- 00:01:04.229 business activities or results. 00:01:04.229 -- 00:01:08.753 Forward-looking statements are based on current expectations and assumptions and are 00:01:08.753 -- 00:01:14.519 subject to risks and uncertainties that could cause actual results or events to material 00:01:14.519 -- 00:01:17.360 differ from those anticipated. 00:01:17.475 -- 00:01:21.998 Additional information regarding these risks and uncertainties is included in the company's 00:01:21.998 -- 00:01:24...